Breaking News, Collaborations & Alliances

Avista to Support Development of an Opioid Addiction Vaccine

Mfg. and dev. partnership with Minneapolis Medical Research Foundation to produce conjugate vaccine to combat substance abuse

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Avista Pharma Solutions has been contracted by the Minneapolis Medical Research Foundation (MMRF) to manufacture an opioid-derived small molecule, a key component of a conjugate vaccine in development to treat opioid addiction. The research is funded by a three-year grant to the MMRF from the National Institute on Drug Abuse. Avista Pharma is registered with the Drug Enforcement Administration (DEA) to handle controlled substances, such as opioids. The manufacturing process to synthesize the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters